NEW YORK (360Dx) – As more research is directed into the use of patients' breath as a basis for medical diagnoses, a consortium of nine European and Middle East partners have joined the fray by developing a nanosensor attached to a smartphone for screening gastric cancer at the point of care.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.